154 GlaxoSmithKline Share capital Nature of trading market Glaxo Wellcome Pence per share Fiscal periods to 26th December 2000 High Low The Ordinary Shares of the company were listed on the London 2000 2110 1440 Stock Exchange on 27th December 2000.
The shares were also 1999 2288 1507 listed on the New York Stock Exchange in the form of American 1998 2073 1465 Depositary Shares ADSs from the same date.
The following table sets out, for the periods indicated, the high US dollars per ADS and low middle market closing quotations in pence for the shares Fiscal periods to 26th December 2000 High Low on the London Stock Exchange, as derived from its Daily Official 3 2000 63 4 46 List, and the high and low last reported sales prices in US dollars 3 1 1999 76 16 48 16 for the ADSs on the New York Stock Exchange, as derived from 1 1 1998 69 2 48 8 the New York Stock Exchange Composite Tape.
Information relating to the share and ADS prices for Glaxo SmithKline Beecham Pence per share Wellcome and SmithKline Beecham prior to the date of the Fiscal periods to 26th December 2000 High Low merger is also given below.
At 3rd March 2003, the number of holders of record of shares in the USA was 1,178 with holdings of 1,845,570 shares, and the number of registered holders of the ADRs was 49,956 with holdings of 272,882,770 ADRs.
Certain of these shares and ADRs were held by brokers or other nominees, as a result the number of holders of record or registered holders in the USA is not representative of the number of beneficial holders or of the residence of beneficial holders.
Control of company As far as is known to the company, it is not directly or indirectly owned or controlled by one or more corporations or by any government.
The company does not know of any arrangements, the operation of which might result in a change in control of the company.
Substantial shareholdings At 3rd March 2003, the company had received notification of the following interest of three per cent or more in its shares: BNY Nominees Limited holds 545,773,383 shares representing 9.07 per cent.
These shares are held on behalf of holders of American Depositary Receipts, which evidence American Depositary Shares Legal & General Investment Management Limited holds 186,857,268 shares representing 3.1 per cent Barclays plc holds 180,980,055 shares representing 3.0 per cent.
As far as is known to the company, no other person was the owner of three per cent or more of the shares of the company.
Directors and Officers The interests of the Directors and Officers of the company as defined in the Companies Act 1985 in share options of the company are given in the Remuneration report pages 39 to 50.
Exchange controls and other limitations affecting security holders There are currently no UK laws, decrees or regulations restricting the import or export of capital or affecting the remittance of dividends or other payments to holders of the companys shares who are non-residents of the UK.
There are no limitations relating only to non-residents of the UK under English law or the companys Memorandum and Articles of Association on the right to be a holder of, and to vote in respect of, the companys shares.
